Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts-Reference-Cited by-同舟云学术

Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts

Published:2015-11-09 Issue:6 Volume:76 Page:1199-1207
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Lee Nikki P.,Chan Kin Tak,Choi Mei Yuk,Lam Ho Yu,Tung Lai Nar,Tzang Fei Chuen,Han Heron,Lam Ian P. Y.,Kwok Sui Yi,Lau Sze Hang,Man Cornelia,Tong Daniel K.,Wong Bing L.,Law Simon

Funder

New B Innovation Limited, Hong Kong

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-015-2897-2.pdf

Reference22 articles.

1. Tong DK, Law S, Kwong DL et al (2011) Current management of cervical esophageal cancer. World J Surg 35:600–607

2. Law S, Kwong DL, Kwok KF et al (2003) Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 238:339–347 (discussion 347–338)

3. Law S, Wong J (2007) The current management of esophageal cancer. Adv Surg 41:93–119

4. Gundersen SI, Palmer AF (2008) Hemoglobin-based oxygen carrier enhanced tumor oxygenation: a novel strategy for cancer therapy. Biotechnol Prog 24:1353–1364

5. Liu XB, Cheng Q, Geng W et al (2014) Enhancement of cisplatin-based TACE by a hemoglobin-based oxygen carrier in an orthotopic rat HCC model. Artif Cells Nanomed Biotechnol 42:229–236

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long noncoding RNAs as potential targets for overcoming chemoresistance in upper gastrointestinal cancers;Biomedicine & Pharmacotherapy;2024-10

2. HBOC alleviated tumour hypoxia during radiotherapy more intensely in large solid tumours than regular ones;Artificial Cells, Nanomedicine, and Biotechnology;2023-11-23

3. Preparation and exchange transfusion effect of a double polymerization human umbilical cord haemoglobin of red blood cell substitute;Artificial Cells, Nanomedicine, and Biotechnology;2023-05-24

4. Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment;Frontiers in Cell and Developmental Biology;2021-03-19

5. The anti-tumoral effects of the oxygen carrier YQ23 in a triple-negative breast cancer syngeneic model;Translational Cancer Research;2021-02